These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8753317)

  • 1. [C-peptide (CPR)].
    Sato Y; Kaku K
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():619-21. PubMed ID: 8753317
    [No Abstract]   [Full Text] [Related]  

  • 2. C-peptide measurement: methods and clinical utility.
    Bonser AM; Garcia-Webb P
    Crit Rev Clin Lab Sci; 1984; 19(4):297-352. PubMed ID: 6373142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus.
    Inukai T; Matsutomo R; Tayama K; Aso Y; Takemura Y
    Exp Clin Endocrinol Diabetes; 1999; 107(1):40-5. PubMed ID: 10077354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
    Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B
    Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
    [No Abstract]   [Full Text] [Related]  

  • 5. [C-peptide].
    Dorner M
    Ann Med Interne (Paris); 1984; 135(6):414-5. PubMed ID: 6508045
    [No Abstract]   [Full Text] [Related]  

  • 6. [The pancreatic reserve in diabetes mellitus by the determination of serum C-peptide using radioimmunoassay].
    Arteaga A; Velasco N; Szegedi AM; Pellegrino MR; López G; Foradori A; Acosta AM
    Rev Med Chil; 1984 Apr; 112(4):321-9. PubMed ID: 6385178
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

  • 8. Appearance of type II diabetes mellitus in type I diabetic recipients of pancreas allografts.
    Hunsicker LG; Smith JL; Yuh WT; Wright FH; Goddard L; Corry RJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2852-3. PubMed ID: 2468245
    [No Abstract]   [Full Text] [Related]  

  • 9. [C-peptide measurement in the classification of diabetes mellitus and in the assessment of requirements for insulin treatment].
    Gjessing HJ
    Ugeskr Laeger; 1990 Feb; 152(9):588-93. PubMed ID: 2408222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical inquiries: What is the best way to distinguish type 1 and 2 diabetes?
    Crownover BK; Nashelsky J; Lo V
    J Fam Pract; 2005 Jul; 54(7):630-2; discussion 630. PubMed ID: 16009095
    [No Abstract]   [Full Text] [Related]  

  • 11. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
    Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
    Kan Y; Chi Z
    Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):16-7, 4. PubMed ID: 1850647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
    Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH
    Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
    Costamaillere L; Arteaga A; Velasco N; Pellegrino MR; Foradori A; López G; Acosta AM
    Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604
    [No Abstract]   [Full Text] [Related]  

  • 15. Identifying latent autoimmune diabetes in adults in Korea: the role of C-peptide and metabolic syndrome.
    Lee SH; Kwon HS; Yoo SJ; Ahn YB; Yoon KH; Cha BY; Lee KW; Son HY
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e62-5. PubMed ID: 19166794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term course of type I-simulating type II-diabetes mellitus].
    Lohmann D; Verlohren HJ; Borsdorf G; Brunner E; Bierwolf B; Richter HV
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(5):241-4. PubMed ID: 6391902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical usefulness of the glucagon test in the study of pancreatic islet cell function].
    Llorente I; Goñi MJ; Forga L; Monreal M; Lizcano F; Moncada E
    Rev Med Univ Navarra; 1992; 37(1):25-9. PubMed ID: 1626165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-peptide and autoimmune markers in diabetes.
    Törn C
    Clin Lab; 2003; 49(1-2):1-10. PubMed ID: 12593469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: A comparison of classification schemes for ketosis-prone diabetes.
    Nalini R; Maldonado M; Balasubramanyam A
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):E1. PubMed ID: 18026157
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of radioimmunoassay in the study of the secretory potential of beta-cells in patients with insulin-independent diabetes mellitus].
    Balabolkin MI; Sharapov AN
    Med Radiol (Mosk); 1984 Nov; 29(11):33-6. PubMed ID: 6390067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.